About Us
We are a pharmaceutical company fighting challenging disease
Alteron Therapeutics focuses on the clinical development of TDP-43 inhibitors for the treatment of cystic fibrosis and neurodegenerative disorders like Alzheimer’s and ALS.
The ALT drugs:
1) are first-in-class TDP-43 inhibiting drugs
2) block TDP-43 nucleic acid binding
3) can penetrate blood brain barrier
4) have shown efficacy in a disease model.
4
Patents
5
Expert Staff
Our Partnership
